LBA16 KEYNOTE-355: Final results from a randomized, double-blind phase III study of first-line pembrolizumab + chemotherapy vs placebo + chemotherapy for metastatic TNBC
Authors:
- J. CortésJCJ. Cortés
- D.W. CesconDCD.W. Cescon
- H.S. RugoHRH.S. Rugo
- S-A. ImSIS-A. Im
- M. Md YusofMYM. Md Yusof
- C. GallardoCGC. Gallardo
- O. LipatovOLO. Lipatov
- C.H. BarriosCBC.H. Barrios
- J. Perez-GarciaJPJ. Perez-Garcia
- H. IwataHIH. Iwata
- N. MasudaNMN. Masuda
- M. Torregroza OteroMOM. Torregroza Otero
- 1 September 2021
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 32, S1289-S1290